195 related articles for article (PubMed ID: 29921372)
1. Expression of proteoglycans in two types of ameloblastoma: novel Immunohistochemical findings.
Gómez-Herrera Z; Molina-Frechero N; Damián-Matsumura P; González-González R; Farfán-Morales JE; Bologna-Molina R
J Biol Regul Homeost Agents; 2018; 32(3):479-487. PubMed ID: 29921372
[TBL] [Abstract][Full Text] [Related]
2. Differential expression profiles between α-dystroglycan and integrin β1 in ameloblastoma: two possible perlecan signalling pathways for cellular growth and differentiation.
Ida-Yonemochi H; Ahsan MS; Saku T
Histopathology; 2011 Jan; 58(2):234-45. PubMed ID: 21255062
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of glypican-1 in ameloblastoma variants.
Bologna-Molina R; Mosqueda-Taylor A; Molina-Frechero N
Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):153-60. PubMed ID: 25046223
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of MDM2 protein in ameloblastomas as compared to adenomatoid odontogenic tumor.
Krishna A; Kaveri H; Naveen Kumar RK; Kumaraswamy KL; Shylaja S; Murthy S
J Cancer Res Ther; 2012; 8(2):232-7. PubMed ID: 22842367
[TBL] [Abstract][Full Text] [Related]
5. Ki-67 expression in dentigerous cysts, unicystic ameloblastomas, and ameloblastomas arising from dental cysts.
Piattelli A; Lezzi G; Fioroni M; Santinelli A; Rubini C
J Endod; 2002 Feb; 28(2):55-8. PubMed ID: 11833688
[TBL] [Abstract][Full Text] [Related]
6. Ameloblastoma and adenomatoid odontogenic tumor: the role of alpha2beta1, alpha3beta1, and alpha5beta1 integrins in local invasiveness and architectural characteristics.
Souza Andrade ES; da Costa Miguel MC; Pinto LP; de Souza LB
Ann Diagn Pathol; 2007 Jun; 11(3):199-205. PubMed ID: 17498594
[TBL] [Abstract][Full Text] [Related]
7. Immunoexpression of integrins in ameloblastoma, adenomatoid odontogenic tumor, and human tooth germs.
de Souza Andrade ES; Miguel MC; de Almeida Freitas R; Pereira Pinto L; Batista de Souza L
Int J Surg Pathol; 2008 Jul; 16(3):277-85. PubMed ID: 18573784
[TBL] [Abstract][Full Text] [Related]
8. Caveolin-1 expression in odontogenic cysts and ameloblastomas.
Jaafari-Ashkavandi Z; Pardis S; Asadzadeh M; Andisheh-Tadbir A; Dehghani-Nazhvani A
Turk Patoloji Derg; 2014; 30(2):94-9. PubMed ID: 24782297
[TBL] [Abstract][Full Text] [Related]
9. Expression of extracellular matrix proteins in ameloblastomas and adenomatoid odontogenic tumors.
de Medeiros AM; Nonaka CF; Galvão HC; de Souza LB; Freitas Rde A
Eur Arch Otorhinolaryngol; 2010 Feb; 267(2):303-10. PubMed ID: 19466441
[TBL] [Abstract][Full Text] [Related]
10. The basement membrane-type heparan sulfate proteoglycan (perlecan) in ameloblastomas: its intercellular localization in stellate reticulum-like foci and biosynthesis by tumor cells in culture.
Ida-Yonemochi H; Ikarashi T; Nagata M; Hoshina H; Takagi R; Saku T
Virchows Arch; 2002 Aug; 441(2):165-73. PubMed ID: 12189507
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of bone remodeling molecules expression in different types of jaw ameloblastoma.
Iakovou M; Chrysomali E; Piperi E; Fanourakis G; Sklavounou A; Vlachodimitropoulos D; Tseleni-Balafouta S
J Oral Pathol Med; 2015 Aug; 44(7):543-51. PubMed ID: 25243582
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of PEA3 in odontogenic cysts and tumors.
Tun KM; Kitkumthorn N; Bumalee D; Arayapisit T; Lapthanasupkul P
J Oral Pathol Med; 2023 Sep; 52(8):777-785. PubMed ID: 37549030
[TBL] [Abstract][Full Text] [Related]
13. Expression of Twist in different subtype of ameloblastomas.
Feng Y; Zhou YM; Hua CG; Tang XF; He DQ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Oct; 108(4):565-70. PubMed ID: 19699120
[TBL] [Abstract][Full Text] [Related]
14. Immunoexpression of BMP-2 and BMP-4 and their receptors, BMPR-IA and BMPR-II, in ameloblastomas and adenomatoid odontogenic tumors.
Nascimento MA; Nonaka CF; Barboza CA; Freitas RA; Pereira Pinto L; Souza LB
Arch Oral Biol; 2017 Jan; 73():223-229. PubMed ID: 27780042
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of p16 and Ki67 immunoexpression in ameloblastomas.
Olimid DA; Florescu AM; Cernea D; Georgescu CC; Mărgăritescu C; Simionescu CE; Stepan AE
Rom J Morphol Embryol; 2014; 55(2):363-7. PubMed ID: 24969987
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD90 and P75NTR stem cell markers in ameloblastomas: a possible role in their biological behavior.
Silva FP; Dias A; Coelho CA; Guerra EN; Marques AE; Decurcio DA; Mantesso A; Cury SE; Silva BS
Braz Oral Res; 2016 Oct; 30(1):e109. PubMed ID: 27737362
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of p53 and murine double minute 2 protein in odontogenic keratocyst versus variants of ameloblastoma.
Singh A; Jain A; Shetty DC; Rathore AS; Juneja S
J Cancer Res Ther; 2020; 16(3):521-529. PubMed ID: 32719261
[TBL] [Abstract][Full Text] [Related]
18. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas.
Kumamoto H; Izutsu T; Ohki K; Takahashi N; Ooya K
J Oral Pathol Med; 2004 May; 33(5):292-9. PubMed ID: 15078490
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical investigation of epidermal growth factor receptor expression in ameloblastomas.
Ueno S; Miyagawa T; Kaji R; Mushimoto K; Shirasu R
J Pathol; 1994 May; 173(1):33-8. PubMed ID: 7931835
[TBL] [Abstract][Full Text] [Related]
20. Ameloblastomas: a regional Latin-American multicentric study.
Ledesma-Montes C; Mosqueda-Taylor A; Carlos-Bregni R; de León ER; Palma-Guzmán JM; Páez-Valencia C; Meneses-García A
Oral Dis; 2007 May; 13(3):303-7. PubMed ID: 17448213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
